I am following Asian Bamboo since a while. The stock was IPOed in Frankfurt at the end of the 2003-2007 bull run mid November 2007 at 17 EUR.
The company is a Chinese company with a Frankfurt stock listing, no direct US or Chinese/Hongkong Listing.
However, since some time DB sponsored ADRs are trading under the Ticker
ASIBY (ADR) in the US.The company's web site (
http://www.asian-bamboo.com/index.asp) states:
The origins of Asian Bamboo AG can be traced back to 1992 when Mr. Lin Zuojun, the CEO and founder, started a bamboo trading business in Fujian province. The business grew rapidly and Mr. Lin built our first bamboo processing plant, located in Mawei, in 1997. In the late 1990s, there was only limited demand for processed bamboo shoots in China, so the Company focused on the Japanese market where we were one of the pioneers in developing the distribution of Chinese processed bamboo shoots. Japan was for many years our most important market until domestic demand took off in the early 2000s. In 2001, we leased our first plantation and since then fresh bamboo shoots and bamboo trees have developed into our largest product categories. Asian Bamboo AG was incorporated in Hamburg and listed on the main board (Prime Market) of the Frankfurt Stock Exchange, under the ticker symbol “5AB”, on 16 November 2007. Using the proceeds from the IPO, we leased more than 10,000 ha of mature plantations in 2008, which instantly more than doubled the size of total mature plantations from the year before.
The companie's stock was hammered in 2008&2009 but tenfolded since March 2009 to a new top auf 40 EUR on 24.09.2010

The company has 15,425,000 shares outstanding, so the total market cap is now a cool 620 mn EUR.
Profit Growth has been extremely strong. The website shows the 3 years since the IPO:
|
|
| 2009 | 2008 | 2007 |
| Revenue | K€ | 58,621 | 43,831 |
| 14,748 |
| Adjusted net profit1 | K€ | 27,847 | 21,193 |
| 6,748 |
Both revenue and Profit almost quadrupelt in the three years from 2007. But what does footnote 1) mean ?
1 Adjusted for changes in the fair value of biological assets and taxes thereon
Aha, that's new for me. They adjust profit for "changes in the fair value of biological assets"...Interesting...
Lets directly jump into Annual Report 2009 to the Balance sheet on Page 65:
"Biological Assets" are 128 mn EUR or more than sixty percent of total equity (200 mn EUR).
Footnote 2.6. of the General accounting policies on page 70 tells us the following:
Therefore, inline with current practice, we have chosen to value our immature plantations by the cost of cultivattion and mature bamboo plantations based on a computation of the present value of expected cashflows according to IAS 41.10, 41.21 and the assumptions used in this calculation.
So let's just understand this: The company
-capitalizes costs for cultivation
-already recognizes future salses of Bamboo to a certain extent
Before we dig deeper into this, the following passage in the Q2 Report on page 7 caught my eye:
Biological Asset Accounting
We are currently in discussion with our auditors about the methods of determining the fair value of biological assets.........we expect that any changes ..... will not have an material impact on the revenue or the adjusted profit numbers.
NOW THIS IS INTERESTING !!!!!
As they are adjusting their profits anyway, there will be certainly no bis issues for those profits, but this certainly means that a large art of the biological assets will most likely dissapear and with that a lot of equity !
Sell side analysts will of course tell us that this doesn't matter, but I would call this:
FINDING NUMBER 1:
Aggressive ( capitalizing expenses, recognizing future sales) and obscure accounting, soon to be restated
To be continued